Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs 2016-06-09 18:45
Patient-reported Outcomes across Phase 3 studies of Baricitinib demonstrate Statistically Significant Improvements in Physical Function and Quality of Life Symptoms in Patients with Rheumatoid Arthritis (RA) 2016-06-09 18:45
Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders 2016-06-08 21:02
Retail Healthcare Transforms as Patients Seek Alternative Healthcare Options Driving Growth Opportunities for Traditional and Non-Traditional Care Givers 2016-06-07 21:35
Results of Clinical and Patient-Reported Outcomes Data for Baricitinib in Patients with Rheumatoid Arthritis to be Presented at Annual European Congress of Rheumatology (EULAR 2016) 2016-06-07 19:00
China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2016 Financial Results 2016-06-07 18:30
New In-Vitro Studies Reinforce Efficacy of BETADINE(R) Skin Cleanser against Viruses that cause Hand Foot & Mouth Disease 2016-06-07 12:33
Takeda to Present New Data at the American Diabetes Association's 76th Scientific Sessions 2016-06-07 01:09
Polaris Group Reports Phase III Study Results of ADI-PEG 20 plus Best Supportive Care in Advanced Hepatocellular Carcinoma 2016-06-07 00:00
FLT-PET Scan Provides Early Evidence of Response to Arginine Depletion by ADI-PEG 20 in Argininosuccinate Synthetase Deficient Thoracic Tumors 2016-06-07 00:00
Novo Nordisk to Present 53 Abstracts at 76th Annual American Diabetes Association Scientific Sessions in New Orleans, LA 2016-06-06 22:03
SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment 2016-06-06 20:54
International Medical Group Gets Social with its Global Service 2016-06-06 20:46
Daiichi Sankyo to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on Thursday, June 9th, 2016 2016-06-06 20:30
Hutchison China MediTech to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on June 10, 2016 2016-06-06 20:30
Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial 2016-06-06 14:03
Extraordinary Conceptions featured on CCTV to discuss international surrogacy 2016-06-06 10:30
Merck Partners with Array BioPharma and Pierre Fabre to Initiate BRAF-mutant CRC Phase III Trial 2016-06-06 08:05
ADI-PEG 20 plus Gemcitabine and nab-Paclitaxel Shows Robust Anti-tumor Activity in Advanced Pancreatic Cancer 2016-06-03 22:00
GE Healthcare and Frost & Sullivan Indonesia Thought Leadership - Next Generation Imaging IT Forum Brings Together Experts to Discuss Innovative IT Solutions in Imaging Workflow 2016-06-03 19:53
1 508 509 510 511 512 520